C3b recognition inhibitors (Attune)

N/A

Report date: 2025/01/26 18:40:01
NME

Base Information

Drug NameC3b recognition inhibitors (Attune)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement system proteins modulators
TargetsComplement system proteins
Therapy Area/IndicationsHemoglobinuria, Paroxysmal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAttune Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesAttune Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsHemoglobinuria, Paroxysmal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A